{
  "actions": [
    {
      "acted_at": "2018-05-17", 
      "action_code": "10000", 
      "references": [], 
      "text": "Introduced in Senate", 
      "type": "action"
    }, 
    {
      "acted_at": "2018-05-17", 
      "action_code": "", 
      "committees": [
        "SSBK"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "s2885-115", 
  "bill_type": "s", 
  "by_request": false, 
  "committee_reports": [], 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "Senate Banking, Housing, and Urban Affairs", 
      "committee_id": "SSBK"
    }
  ], 
  "congress": "115", 
  "cosponsors": [
    {
      "bioguide_id": "B001230", 
      "district": null, 
      "name": "Baldwin, Tammy", 
      "original_cosponsor": false, 
      "sponsored_at": "2018-06-13", 
      "state": "WI", 
      "title": "Sen", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2018-05-17", 
  "number": "2885", 
  "official_title": "A bill to amend the Securities Exchange Act of 1934 to require additional disclosure for pharmaceutical companies.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Disclosing Pharmaceutical Company Windfall Profits Act of 2018", 
  "sponsor": {
    "bioguide_id": "S001203", 
    "district": null, 
    "name": "Smith, Tina", 
    "state": "MN", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2018-05-17", 
  "subjects": [
    "Finance and financial sector"
  ], 
  "subjects_top_term": "Finance and financial sector", 
  "summary": {
    "as": "Introduced in Senate", 
    "date": "2018-05-17T04:00:00Z", 
    "text": "Disclosing Pharmaceutical Company Windfall Profits Act of 2018 \n\nThis bill amends the Securities Exchange Act of 1934 to require pharmaceutical companies to make certain public disclosures, including disclosures related to taxation, compensation, dividends, and spending on research and development."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "A bill to amend the Securities Exchange Act of 1934 to require additional disclosure for pharmaceutical companies.", 
      "type": "official"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Disclosing Pharmaceutical Company Windfall Profits Act of 2018", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Disclosing Pharmaceutical Company Windfall Profits Act of 2018", 
      "type": "short"
    }, 
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "Disclosing Pharmaceutical Company Windfall Profits Act of 2018", 
      "type": "display"
    }
  ], 
  "updated_at": "2019-05-01T14:27:31Z", 
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/115/s/BILLSTATUS-115s2885.xml"
}